Patients with poor early clinical outcomes after anatomic total shoulder arthroplasty have sustained poor performance at 2 years from surgery

Eur J Orthop Surg Traumatol. 2023 Dec;33(8):3661-3669. doi: 10.1007/s00590-023-03585-z. Epub 2023 Jun 5.

Abstract

Purpose: We sought to define the risk of persistent shoulder dysfunction after anatomic total shoulder arthroplasty (aTSA) beyond the early postoperative period and identify risk factors for persistent poor performance.

Methods: We retrospectively identified 144 primary aTSAs performed for primary osteoarthritis with early poor performance and 2-year minimum follow-up. Early poor performance was defined as a postoperative ASES score below the 20th percentile at 3- or 6-months (62 and 72 points, respectively). Persistent poor performance at 2 years was defined as failing to achieve the patient acceptable symptomatic state (PASS) [ASES = 81.7 points].

Results: At 2-year follow-up, 51% (n = 74) of patients with early poor performance at either 3- or 6-month follow-up had persistent poor performance. There was no difference in the rate of persistent poor performance if patients were poor performers at the 3-, 6-month follow-up, or both (50% vs. 49% vs. 56%, P = .795). Of aTSAs achieving the PASS at 2-year follow-up, a greater proportion exceeded the minimal clinically important differences (MCID) [Forward elevation, external rotation, and all outcome scores] and substantial clinical benefit (SCB) [external rotation and all outcome scores] compared to persistent poor performers. However, over half of persistent poor performers still exceeded the MCID for all outcome measures (56-85%). Independent predictors of persistent poor performance were hypertension (2.61 [1.01-6.72], P = .044) and diabetes (5.14 [1.00-26.4], P = .039).

Conclusion: Over half of aTSAs with an ASES score < 20th percentile at early follow-up had continued poor shoulder function at 2-years postoperatively. Persistent poor performance was best projected by preoperative hypertension and diabetes.

Level of evidence: Level III; Retrospective Cohort Comparison using Large Database; Treatment Study.

Keywords: Anatomical shoulder arthroplasty; Poor outcome; Shoulder replacement; Underperformer.

MeSH terms

  • Arthroplasty, Replacement, Shoulder* / adverse effects
  • Diabetes Mellitus*
  • Humans
  • Hypertension* / surgery
  • Range of Motion, Articular
  • Retrospective Studies
  • Shoulder Joint* / surgery
  • Treatment Outcome